Korea FilingsFull brief — $39

InBody Co., Ltd.

(주)인바디 · KOSDAQ: 041830 · Medical, precision and optical instruments

Key facts

Korean name
(주)인바디
Market / ticker
KOSDAQ · 041830
Industry
Medical, precision and optical instruments
Established
1996-05-15
Fiscal year ends
December
Website
www.inbody.com
DART corp code
00269922
Latest revenue
₩233.9B (FY2025)

Items worth checking

No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩170.4B₩204.5B₩233.9B
Operating income₩38.3B₩36.7B₩36.8B
Net income₩36.6B₩32.7B₩30.0B
Total assets₩274.5B₩305.8B₩361.1B
Total liabilities₩24.6B₩31.9B₩41.3B
Total equity₩249.8B₩273.9B₩319.8B
Share capital₩6.8B₩6.8B₩6.8B

Consolidated statements · FY2025 operating margin 15.7% · liabilities to equity 13% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 30 (current)성현회계법인Unqualified
Term 29 (prior)성현회계법인Unqualified
Term 28 (two years prior)안진회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-10Large shareholding (5%+) reportDART
2026-08-14Treasury share disposal results reportDART
2026-08-14Half-year report (2026.06)DART
2026-08-12Large shareholding (5%+) reportDART
2026-08-06Amended: Material event report — Treasury share disposal decisionDART
2026-08-06Material event report — Treasury share disposal decisionDART
2026-08-06Preliminary consolidated operating results (fair disclosure)DART
2026-08-03Large shareholding (5%+) reportDART
2026-07-03Large shareholding (5%+) reportDART
2026-06-26Large shareholding (5%+) reportDART
2026-06-04Large shareholding (5%+) reportDART
2026-05-28Officer / major shareholder ownership reportDART
2026-05-28Treasury share disposal results reportDART
2026-05-20Material event report — Treasury share disposal decisionDART
2026-05-14Quarterly report (2026.03)DART
2026-05-07Preliminary consolidated operating results (fair disclosure)DART
2026-04-28Large shareholding (5%+) reportDART
2026-04-28Large shareholding (5%+) reportDART
2026-03-27Corporate value-up plan (voluntary)DART
2026-03-26Annual general meeting resultsDART

Showing the 20 most recent of 45 filings. The full brief lists all of them.

Full brief on InBody Co., Ltd. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Medical, precision and optical instruments

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.